Atlas Trials

Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins

Clinical trial NCT06481878 · RECRUITING

Trial details

NCT number
NCT06481878
Sponsor
University Hospital, Grenoble
Status
RECRUITING
Study type
OBSERVATIONAL
Alzheimer Disease
Start date
2024-10-11
Primary completion
2027-10-06
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.